Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SYNTHETIC PEPTIDE SP2 AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/093427
Kind Code:
A1
Abstract:
Provided is a synthetic peptide having the amino acid sequence shown in SEQ ID No. 1, the peptide having obvious anti-tumour growth activity on xenograft tumours such as subcutaneous human pancreatic cancer, human cervical cancer, and human ovarian cancer in nude mice, and having the effect of delaying metastasis and prolonging the survival time of nude mice having orthotopic transplantation of human pancreatic cancer and lung adenocarcinoma; after the animals were given intravenous injection of sp2 at a dose of 2000 mg/kgBW, no toxicity reaction and death were observed, being highly safe. Also provided are uses for the Sp2 in (1) preventing and/or treating of tumours; (2) inhibiting tumour cell proliferation and/or growth and/or invasion; (3) strengthening the anti-tumour immune response; (4) inducing tumour cell differentiation; (5) preparing a class of anti-tumour drugs; (6) inhibiting tumour telomerase activity; (7) regulating the tumour cell cycle; and (8) preparing a class of products for regulating the tumour cell cycle.

Inventors:
ZHANG WANQIN (CN)
LI YINTIAN (CN)
JI XUEWEN (CN)
ZHAO LIMEI (CN)
Application Number:
PCT/CN2018/115567
Publication Date:
May 14, 2020
Filing Date:
November 15, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TAIAN CITY QIHANG BIOTECHNOLOGY CO (CN)
International Classes:
A61K38/10; C07K7/08; A61P35/00
Foreign References:
CN103819554A2014-05-28
Other References:
DATABASE GenBank 13 April 2016 (2016-04-13), "venom toxin meuTx20 [Mesobuthus eupeus] - Protein - NCBI", XP055704961, Database accession no. AMX81493.1
DATABASE GenBank 22 November 2017 (2017-11-22), XP055704963, Database accession no. D9U2B5.1
Attorney, Agent or Firm:
DALIAN EAST PATENT AGENT LTD. (CN)
Download PDF: